Trump’s tariff regime still has companies in contingency mode
Donald Trump’s tariff program is still forcing companies to plan around shifting dates and layered exceptions instead of a clean, settled rule set. In late February, the White House announced a temporary import surcharge tied to what it called fundamental international payments problems. In April, it added new tariff actions on patented pharmaceuticals and on aluminum, steel and copper imports. The result is a calendar full of separate triggers, not a single rule companies can treat as finished. ([whitehouse.gov](https://www.whitehouse.gov/presidential-actions/2026/02/imposing-a-temporary-import-surcharge-to-address-fundamental-international-payments-problems/))
The February proclamation was dated February 20, 2026 and says the surcharge takes effect on February 24 for 150 days. The April pharmaceutical fact sheet is dated April 2, 2026 and says patented pharmaceutical products and ingredients face a 100% tariff, with a 15% tariff for products from the European Union, Japan, Korea, Switzerland and Liechtenstein, while generic pharmaceuticals, biosimilars and associated ingredients are not subject to tariffs at this time. The companion proclamation also sets zero-rate treatment for certain orphan-drug and other specialty categories in specific circumstances. ([whitehouse.gov](https://www.whitehouse.gov/presidential-actions/2026/02/imposing-a-temporary-import-surcharge-to-address-fundamental-international-payments-problems/))
The metals action is dated April 2, 2026 as well, but the higher duties hit on April 6. The White House said the new rates would apply to aluminum, steel and copper imports entered for consumption on or after 12:01 a.m. Eastern time that day, with the proclamation spelling out different treatment for some goods from the United Kingdom and some products made entirely from U.S.-origin metal. ([whitehouse.gov](https://www.whitehouse.gov/presidential-actions/2026/04/strengthening-actions-taken-to-adjust-imports-of-aluminum-steel-and-copper-into-the-united-states/))
That kind of tariff structure keeps customs teams, purchasing departments and logistics planners busy because it changes the answer depending on what the product is, where it came from and when it arrives. Companies can work around high duties when the rules are stable. They have a much harder time when they have to match invoices, contracts and shipment dates to a stack of overlapping deadlines and carveouts. The White House says the actions are about national security, supply chains and domestic manufacturing. For importers, they are also a reminder that the policy can still move under their feet. ([whitehouse.gov](https://www.whitehouse.gov/fact-sheets/2026/04/fact-sheet-president-donald-j-trump-bolsters-national-security-and-strengthens-u-s-supply-chains-by-imposing-tariffs-on-patented-pharmaceutical-products/))
Comments
Threaded replies, voting, and reports are live. New users still go through screening on their first approved comments.
Log in to comment
No comments yet. Be the first reasonably on-topic person here.